Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial

The REMAP-CAP Investigators, Lennie P.G. Derde, Anthony C. Gordon, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Alistair D. Nichol, Yaseen M. Arabi, Djillali Annane, Abi Beane, Richard Beasley, Zahra Bhimani, Marc J.M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Adrian Buzgau, Meredith Buxton, Allen C. Cheng, Nicola Cooper, Matt Cove, Olaf L. Cremer, Michelle A. Detry, Eamon J. Duffy, Lise J. Estcourt, Mark Fitzgerald, James Galea, Herman Goossens, Rashan Haniffa, Thomas E. Hills, Nao Ichihara, Andrew King, Francois Lamontagne, Patrick R. Lawler, Helen L. Leavis, Roger J. Lewis, Kelsey M. Linstrum, Edward Litton, John C. Marshall, Florian B. Mayr, Danny McAuley, Anna McGlothlin, Shay P McGuinness, Bryan J. McVerry, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Mihai G. Netea, Kayode Ogungbenro, Katrina Orr BPharm, Rachael L. Parke, Jane C. Parker, Asad E. Patanwala, Ville Pettila, Luis Felipe Reyes, Ashish Sanil, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Manoj Saxena, Christopher W. Seymour, Manu Shankar-Hari, Wendy I. Sligl, Alexis F. Turgeon, Anne M. Turner, Steven Tong, Suvi Vaara, Taryn Youngstein, Ryan Zarychanski, Cameron Green, Alisa M. Higgins, Colin J. McArthur, Lindsay R. Berry, Elizabeth Lorenzi, Scott Berry, Steve A. Webb, Derek C. Angus, Frank L. van de Veerdonk
doi: https://doi.org/10.1101/2021.06.18.21259133

Article Information

doi 
https://doi.org/10.1101/2021.06.18.21259133
History 
  • June 22, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. The REMAP-CAP Investigators,
  2. Lennie P.G. Derde, MD, PhD1,*,
  3. Anthony C. Gordon, MBBS, MD2,3,
  4. Paul R. Mouncey, MSc4,
  5. Farah Al-Beidh, PhD2,
  6. Kathryn M. Rowan, PhD4,
  7. Alistair D. Nichol, MD, PhD5,6,7,
  8. Yaseen M. Arabi, MD8,
  9. Djillali Annane, MD, PhD9,10,11,
  10. Abi Beane, PhD12,
  11. Richard Beasley13,
  12. Zahra Bhimani, MPH14,
  13. Marc J.M. Bonten, MD, PhD1,
  14. Charlotte A. Bradbury, MBChB, PhD15,
  15. Frank M. Brunkhorst, MD, PhD16,
  16. Adrian Buzgau, MSc5,
  17. Meredith Buxton17,
  18. Allen C. Cheng, MD, PhD5,7,
  19. Nicola Cooper2,3,
  20. Matt Cove, MBChB19,
  21. Olaf L. Cremer, MD, PhD1,
  22. Michelle A. Detry, PhD20,
  23. Eamon J. Duffy, BPharm21,
  24. Lise J. Estcourt, MBBCh, PhD22,
  25. Mark Fitzgerald, PhD20,
  26. James Galea23,
  27. Herman Goossens, PhD24,
  28. Rashan Haniffa, PhD25,26,27,
  29. Thomas E. Hills, PhD13,28,
  30. Nao Ichihara29,
  31. Andrew King23,
  32. Francois Lamontagne, MD30,
  33. Patrick R. Lawler, MD, MPH31,32,
  34. Helen L. Leavis, MD, PhD1,
  35. Roger J. Lewis, MD, PhD20,33,
  36. Kelsey M. Linstrum, MS34,
  37. Edward Litton, MD, PhD35,36,
  38. John C. Marshall, MD14,
  39. Florian B. Mayr, MD, MPH34,
  40. Danny McAuley, MD37,38,
  41. Anna McGlothlin, PhD20,
  42. Shay P McGuinness, MD5,21,28,
  43. Bryan J. McVerry, MD34,
  44. Stephanie K. Montgomery, MSc34,
  45. Susan C. Morpeth, MD, PhD28,39,
  46. Srinivas Murthy, MD40,
  47. Mihai G. Netea41,
  48. Kayode Ogungbenro23,
  49. Katrina Orr BPharm35,
  50. Rachael L. Parke, PhD13,43,
  51. Jane C. Parker, BN5,
  52. Asad E. Patanwala, PharmD, MPH44,45,
  53. Ville Pettila, MD46,
  54. Luis Felipe Reyes47,48,
  55. Ashish Sanil20,
  56. Hiroki Saito49,
  57. Marlene S. Santos, MD, MSHS14,
  58. Christina T. Saunders, PhD20,
  59. Manoj Saxena50,
  60. Christopher W. Seymour, MD, MSc34,
  61. Manu Shankar-Hari, MD, PhD51,52,
  62. Wendy I. Sligl, MD, MSc53,
  63. Alexis F. Turgeon, MD, MSc54,
  64. Anne M. Turner, MPH13,
  65. Steven Tong55,
  66. Suvi Vaara46,
  67. Taryn Youngstein2,3,
  68. Ryan Zarychanski, MD, MSc56,
  69. Cameron Green, MSc5,
  70. Alisa M. Higgins, PhD5,
  71. Colin J. McArthur, MD28,
  72. Lindsay R. Berry, PhD20,
  73. Elizabeth Lorenzi, PhD20,
  74. Scott Berry, PhD20,
  75. Steve A. Webb, MD, PhD5,57,
  76. Derek C. Angus, MD, MPH34 and
  77. Frank L. van de Veerdonk, MD, PhD41
  1. 1University Medical Center Utrecht, Utrecht, The Netherlands
  2. 2Imperial College London, London, United Kingdom
  3. 3Imperial College Healthcare NHS Trust, St. Mary’s Hospital, London, United Kingdom
  4. 4Intensive Care National Audit & Research Centre (ICNARC), London, United Kingdom
  5. 5Monash University, Melbourne, Australia
  6. 6University College Dublin, Dublin, Ireland
  7. 7Alfred Health, Melbourne, Australia
  8. 8King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
  9. 9Hospital Raymond Poincaré (Assistance Publique Hópitaux de Paris), Garches, France
  10. 10Université Versailles SQY - Université Paris Saclay, Montigny-le-Bretonneux, France
  11. 11Université Paris Saclay - UVSQ – INSERM, Garches, France
  12. 12University of Oxford, Oxford, United Kingdom
  13. 13Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand
  14. 14St. Michael’s Hospital Unity Health, Toronto, Canada
  15. 15University of Bristol, Bristol, United Kingdom
  16. 16Jena University Hospital, Jena, Germany
  17. 17Global Coalition for Adaptive Research, San Francisco, California
  18. 19National University of Singapore
  19. 20Berry Consultants, Austin, United States
  20. 21Auckland District Health Board, Auckland, New Zealand
  21. 22NHS Blood and Transplant, Oxford, United Kingdom
  22. 23University of Manchester, Manchester, United Kingdom
  23. 24University of Antwerp, Wilrijk, Belgium
  24. 25University of Oxford, Bangkok, Thailand
  25. 26University College London Hospital, London, United Kingdom
  26. 27National Intensive Care Surveillance (NICST), Colombo, Sri Lanka
  27. 28Auckland City Hospital, Auckland, New Zealand
  28. 29Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  29. 30Université de Sherbrooke, Sherbrooke, Quebec, Canada
  30. 31University Health Network, Toronto, Canada
  31. 32University of Toronto, Toronto, Canada
  32. 33Harbor-UCLA Medical Center, Torrance, CA, United States
  33. 34University of Pittsburgh, Pittsburgh, United States
  34. 35Fiona Stanley Hospital, Perth, Australia
  35. 36University of Western Australia, Perth, Australia
  36. 37Queen’s University Belfast, Belfast, Northern Ireland
  37. 38Royal Victoria Hospital, Belfast, Northern Ireland
  38. 39Middlemore Hospital, Auckland, New Zealand
  39. 40University of British Columbia, Vancouver, Canada
  40. 41Radboudumc, Nijmegen, The Netherlands
  41. 43University of Auckland, Auckland, New Zealand
  42. 44University of Sydney, Sydney, Australia
  43. 45Royal Prince Alfred Hospital, Sydney, Australia
  44. 46University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  45. 47Universidad de La Sabana, Chia, Colombia
  46. 48Clínica Universidad de La Sabana, Chia, Colombia
  47. 49Yokohama City Seibu Hospital, Yokohama
  48. 50The George Institute for Global Health, Sydney, Australia
  49. 51King’s College London, London, United Kingdom
  50. 52Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
  51. 53University of Alberta, Edmonton, Canada
  52. 54Université Laval, Québec City, Canada
  53. 55Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
  54. 56University of Manitoba, Winnipeg, Canada
  55. 57St John of God Hospital, Subiaco, Australia
  1. ↵*Corresponding Author
    Lennie P G Derde, MD, PhD, Division Vital Functions, Intensive Care Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands, Email: l.p.g.derde{at}umcutrecht.nl
Back to top
Posted June 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial
The REMAP-CAP Investigators, Lennie P.G. Derde, Anthony C. Gordon, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Alistair D. Nichol, Yaseen M. Arabi, Djillali Annane, Abi Beane, Richard Beasley, Zahra Bhimani, Marc J.M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Adrian Buzgau, Meredith Buxton, Allen C. Cheng, Nicola Cooper, Matt Cove, Olaf L. Cremer, Michelle A. Detry, Eamon J. Duffy, Lise J. Estcourt, Mark Fitzgerald, James Galea, Herman Goossens, Rashan Haniffa, Thomas E. Hills, Nao Ichihara, Andrew King, Francois Lamontagne, Patrick R. Lawler, Helen L. Leavis, Roger J. Lewis, Kelsey M. Linstrum, Edward Litton, John C. Marshall, Florian B. Mayr, Danny McAuley, Anna McGlothlin, Shay P McGuinness, Bryan J. McVerry, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Mihai G. Netea, Kayode Ogungbenro, Katrina Orr BPharm, Rachael L. Parke, Jane C. Parker, Asad E. Patanwala, Ville Pettila, Luis Felipe Reyes, Ashish Sanil, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Manoj Saxena, Christopher W. Seymour, Manu Shankar-Hari, Wendy I. Sligl, Alexis F. Turgeon, Anne M. Turner, Steven Tong, Suvi Vaara, Taryn Youngstein, Ryan Zarychanski, Cameron Green, Alisa M. Higgins, Colin J. McArthur, Lindsay R. Berry, Elizabeth Lorenzi, Scott Berry, Steve A. Webb, Derek C. Angus, Frank L. van de Veerdonk
medRxiv 2021.06.18.21259133; doi: https://doi.org/10.1101/2021.06.18.21259133
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area